Treatment Program for Anemia in AIDS Patients

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

NCT00002071 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

NCT00270270 ·Status: COMPLETED ·Phase: PHASE2

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia

NCT00002042 ·Status: COMPLETED ·Phase: NA

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

NCT00002073 ·Status: COMPLETED ·Phase: NA

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

NCT00058331 ·Status: COMPLETED ·Phase: PHASE3

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

NCT03277183 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

NCT00270010 ·Status: COMPLETED ·Phase: PHASE2

Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

NCT01290328 ·Status: TERMINATED ·Phase: NA

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

NCT00701714 ·Status: TERMINATED ·Phase: PHASE3

Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)

NCT02522975 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy

NCT00270283 ·Status: COMPLETED ·Phase: PHASE2

Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery

NCT02210949 ·Status: TERMINATED ·Phase: PHASE4

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

NCT00144495 ·Status: COMPLETED ·Phase: PHASE3

Intravenous Treatment of Anemia in Pregnancy

NCT03317210 ·Status: COMPLETED ·Phase: PHASE4

Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.

NCT00210743 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT

NCT00002302 ·Status: COMPLETED ·Phase: NA

Predictors of Response to Iron and Erythropoietin Stimulating Agents

NCT03658876 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis

NCT00146224 ·Status: COMPLETED ·Phase: PHASE3

Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)

NCT00398749 ·Status: COMPLETED

The Effect of Human Recombinant Erythropoietin in Acute Renal Failure

NCT03102021 ·Status: COMPLETED ·Phase: PHASE2

The Benefits of a Preoperative Anemia Management Program

NCT01888003 ·Status: TERMINATED ·Phase: NA

Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

NCT00437450 ·Status: UNKNOWN ·Phase: PHASE2

Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)

NCT00286182 ·Status: COMPLETED ·Phase: PHASE2

A Safety Study of Pentoxifylline for the Treatment of Anemia

NCT01102218 ·Status: TERMINATED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

NCT00711958 ·Status: COMPLETED ·Phase: PHASE3